Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer
about
Isolated and Syndromic Retinal Dystrophy Caused by Biallelic Mutations in RCBTB1, a Gene Implicated in UbiquitinationIDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patientsIsocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate.Metabolic requirements for the maintenance of self-renewing stem cells.Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation.Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressorsMolecular pathogenesis and mechanisms of thyroid cancerCorrelation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinomaMutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation.TET proteins and the control of cytosine demethylation in cancer.Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients.Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma.Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes.Cancer-associated isocitrate dehydrogenase mutationsEmploying genetic markers to improve diagnosis of thyroid tumor fine needle biopsy.Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomasAn investigation into the cytotoxic effects of 13-acetoxysarcocrassolide from the soft coral Sarcophyton crassocaule on bladder cancer cellsTreatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.Alterations of metabolic genes and metabolites in cancer.Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in miceIsocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomasRecent progress of genome study for anaplastic thyroid cancer.Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomas.Role of isocitrate dehydrogenase in glioma.Lipids and prostate cancer.IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectivesRare insights into cancer biology.Genetics and epigenetics of sporadic thyroid cancer.Metabolic alteration in tumorigenesis.Cancer development, progression, and therapy: an epigenetic overview.5-hydroxymethylcytosine profiling as an indicator of cellular state.Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.The emerging role and targetability of the TCA cycle in cancer metabolism.Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria.A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors.Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.Clinicopathological features and molecular analysis of primary glioblastomas in Moroccan patients.Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production.Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo.Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.
P2860
Q28385856-AB5820BA-B163-45EC-ABC4-B44F54189202Q33597773-80077814-9F8F-4710-B671-FC4BB5189F03Q33699608-82728F36-33C6-443E-AD0F-7D5CD4498710Q33893346-771EBF5F-CED1-4B53-A3FD-502CAF35A5B1Q34258768-3F33BDC2-B0A6-4BB7-94A7-2F530E009012Q34279708-72FDD544-04EF-40EA-BECD-36A4EE8D322AQ34329018-A12A44FF-D8B3-4941-98F6-2DBD9798FDB7Q34588501-8657EF11-373A-4E25-AC12-65AF3FF485DFQ34755642-C8B45224-44D4-4209-B40D-41AEF70D7208Q35021377-82D136A5-1D0F-4E90-96DC-0A7B74E4FA8CQ35057314-5F3AEF2C-EC9E-486C-89F7-62CC9EE54671Q35441165-8EF9A54F-96B0-4F2A-BAE2-37A115E41FBBQ35687860-8A447ED3-A919-4C8B-A036-BA3DAC18B61BQ35705274-5BA79341-7929-4849-A647-3D6878FFED2BQ35731026-4BC7BC35-657A-4C9B-9EEE-C224DD072E66Q35731037-3C125F00-F558-44F7-8850-CF22F0F7E826Q35760042-FB27132A-D49D-44D1-A281-988C0D4AEC9EQ35774484-D88DBC2B-4986-41E6-8C37-A74C0CF5D246Q35957146-AC7A5102-B87E-4CC9-B7D2-E23774CE4109Q36501683-39621FBE-BEE2-4A3A-BDDF-66DCB08B8957Q36925070-486B621F-C12D-4C6D-88BE-73D753AB3C53Q36992782-38BC41E5-AC84-41F5-83F4-0C13B443039FQ37835774-44DA79E3-013E-404D-9288-BC2DC04EFE9CQ37939994-AC08418A-8F37-456A-9A82-1BDE47EE8D46Q38002682-4A72811C-3202-4BBA-A48B-00E793D253D9Q38052534-3448E1C8-6D9A-4BCB-98C2-32D404EC8295Q38118122-983ACDFB-5F99-4806-8EEF-75EC7090BB9BQ38128097-DBEB2458-6B1B-4C7F-AF9E-18B7737ECDFCQ38151521-634B493F-CFB4-4B02-8248-2BBE1A0B012AQ38154977-7C22FD5C-298A-44CE-A1E7-929FA6EB0A61Q38166838-F7739B2C-FE09-44E0-B42F-1FAE522124E0Q38657760-AD621D1A-0055-4B68-AF4C-0CBEE2EA428CQ38658458-3E74F330-1000-4709-A5F0-1DB2397A72C8Q38658533-2D760E8A-4D19-4BD3-9D05-3A5C8C73B6D2Q38712122-9AE8EE42-6444-4F8A-8E1F-4D0281E96865Q38823954-FE2C1666-2299-4F94-B348-87653424572CQ39068086-7A90BF48-CF39-4702-B29A-7DFB8E76EB47Q39458545-DC718F4A-2BE6-4474-B418-59C5E66696C8Q40319899-7188136C-9DE6-4D1F-A4DD-3532C3924BE1Q41677197-227BECF9-69AA-4D5B-AEE6-52F40C7ABA5E
P2860
Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification and functional ...... 1) mutations in thyroid cancer
@ast
Identification and functional ...... 1) mutations in thyroid cancer
@en
Identification and functional ...... 1) mutations in thyroid cancer
@en-gb
Identification and functional ...... 1) mutations in thyroid cancer
@nl
type
label
Identification and functional ...... 1) mutations in thyroid cancer
@ast
Identification and functional ...... 1) mutations in thyroid cancer
@en
Identification and functional ...... 1) mutations in thyroid cancer
@en-gb
Identification and functional ...... 1) mutations in thyroid cancer
@nl
prefLabel
Identification and functional ...... 1) mutations in thyroid cancer
@ast
Identification and functional ...... 1) mutations in thyroid cancer
@en
Identification and functional ...... 1) mutations in thyroid cancer
@en-gb
Identification and functional ...... 1) mutations in thyroid cancer
@nl
P2093
P2860
P921
P1476
Identification and functional ...... 1) mutations in thyroid cancer
@en
P2093
Avaniyapuram Kannan Murugan
Ermal Bojdani
Mingzhao Xing
P2860
P356
10.1016/J.BBRC.2010.02.095
P407
P577
2010-03-12T00:00:00Z